Sonnet BioTherapeutics Holdings Inc

NASDAQ:SONN 4:00:00 PM EDT

2.83

-0.02 (-0.88%)

5:48:29 PM EDT: $2.77 -0.06 (-2.12%)

Sonnet BioTherapeutics Holdings Inc Stock, NASDAQ:SONN

100 Overlook Center, Suite 102, Princeton, New Jersey 08540

United States of America

Phone: +1.609.375.2227

Number of Employees: 12

http://www.sonnetbio.com

Description

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded in 2011 and is headquartered in Princeton, NJ.